We describe a case of giant cavernous haemangioma of the liver with disseminated intravascular coagulopathy (Kasabach-Merritt syndrome) which was cured by orthotopic liver transplant.
INTRODUCTION
Cavernous haemangioma is the most common benign tumour of the liver and is usually solitary and less than 4 cm in diameter. Giant hepatic haemangioma is uncommon, rarely causes symptoms and requires no specific treatment when asymptomatic.
The Kasabach-Merritt syndrome (KMS) describes the occurence of disseminated intravascular coagulopathy (DIC) with a large haemangioma and was first observed in association with a cutaneous haemangioma. The After the initial surgical assessment, it was considered that the only therapeutic option which might achieve cure was a liver transplantation. Figure 3 . Multiple old and recent thrombi were seen within the haemangioma. 
DISCUSSION
The vast majority of hepatic cavernous haemangiomas remain asymptomatic and are discovered incidentally. Rarely, a large haemangioma may cause right upper quadrant pain, but the potential for rupture is negligible and does not in itself constitute an indication for resection. Malignant transformation is unknown.
KMS is a consumptive coagulopathy described originally in association with cutaneous haemangiomas in children. This coagulopathy is thought to be related to a localised form ofintravascular coagulation within the haemangioma. KMS associated with hepatic haemangiomas is rare, but well-known, and raises a number of management problems. The presence of an ongoing coagulopathy raised technical problems during the OLT. Because of the improvement of the DIC and a concern about intraoperative and postoperative bleeding the low dose heparin infusion was stopped before the OLT. This heparin-free period was associated with decreased fibrinogen and increased FDP. The rapid clotting of the femoral cannula at the beginning of the procedure, in conjunction with the preoperative abnormal antithrombin levels, raised further concern about concomitant hypercoagulability and the aprotinin infusion was ceased. In retrospect, it may have been optimal to continue heparin until the end of the hepatectomy to control the DIC and to prevent the clotting of the venous accesses.
OLT can be performed safely in gianthaemangiomata complicated by KMS when resection is necessary but technically impossible.
